Explore the key insights from Marker Therapeutics, Inc.'s 8-K filing dated February 12, 2025, highlighting financial metrics and corporate details. Stock symbol: MRKR.
Explore Marker Therapeutics, Inc.'s 8-K filing from December 23, 2024, highlighting essential updates for investors. Stay informed on MRKR's latest significant event!
Explore the latest 8-K filing from Marker Therapeutics (MRKR) dated December 17, 2024, detailing significant developments and compliance insights for investors.
Explore Marker Therapeutics, Inc.'s recent 8-K filing from December 19, 2024, revealing significant corporate events. Stay informed on biotech investment opportunities.